129 related articles for article (PubMed ID: 11896678)
1. In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.
Kowara R; Karaczyn AA; Fivash MJ; Kasprzak KS
Chem Res Toxicol; 2002 Mar; 15(3):319-25. PubMed ID: 11896678
[TBL] [Abstract][Full Text] [Related]
2. Fluorimetric detection of enzymatic activity associated with the human tumor suppressor Fhit protein.
Asensio AC; Oaknin S; Rotllán P
Biochim Biophys Acta; 1999 Jul; 1432(2):396-400. PubMed ID: 10407161
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
[TBL] [Abstract][Full Text] [Related]
4. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of influence of Ap4A analogues on Fhit-positive HEK293T cells; cytotoxicity and ability to induce apoptosis.
Krakowiak A; Pęcherzewska R; Kaczmarek R; Tomaszewska A; Nawrot B; Stec WJ
Bioorg Med Chem; 2011 Aug; 19(16):5053-60. PubMed ID: 21757356
[TBL] [Abstract][Full Text] [Related]
6. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
7. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Inhibitors of the Tumor Suppressor Fhit.
Lange S; Hacker SM; Schmid P; Scheffner M; Marx A
Chembiochem; 2017 Sep; 18(17):1707-1711. PubMed ID: 28643453
[TBL] [Abstract][Full Text] [Related]
9. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy.
Zawacka-Pankau J; Kowalska A; Issaeva N; Burcza A; Kwiek P; Bednarz N; Pramanik A; Banecki B; Podhajska AJ
J Photochem Photobiol B; 2007 Jan; 86(1):35-42. PubMed ID: 16990010
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of Escherichia coli (MutT) and human (MTH1) 8-oxo-dGTPases to in vitro inhibition by the carcinogenic metals, nickel(II), copper(II), cobalt(II) and cadmium(II).
Porter DW; Yakushiji H; Nakabeppu Y; Sekiguchi M; Fivash MJ; Kasprzak KS
Carcinogenesis; 1997 Sep; 18(9):1785-91. PubMed ID: 9328176
[TBL] [Abstract][Full Text] [Related]
14. Expression in Escherichia coli and simple purification of human Fhit protein.
Pawelczyk T; Kowara R; Golebiowski F; Matecki A
Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
[TBL] [Abstract][Full Text] [Related]
15. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
16. Diadenosines as FHIT-ness instructors.
Campiglio M; Bianchi F; Andriani F; Sozzi G; Tagliabue E; Ménard S; Roz L
J Cell Physiol; 2006 Aug; 208(2):274-81. PubMed ID: 16547961
[TBL] [Abstract][Full Text] [Related]
17. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.
Huang K; Arabshahi A; Wei Y; Frey PA
Biochemistry; 2004 Jun; 43(23):7637-42. PubMed ID: 15182206
[TBL] [Abstract][Full Text] [Related]
19. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors.
Kawaguchi M; Sekimoto E; Ohta Y; Ieda N; Murakami T; Nakagawa H
J Med Chem; 2021 Jul; 64(13):9567-9576. PubMed ID: 34160227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
